Steering Treatments for Major Depressive Disorder episode artwork

EPISODE · Jul 14, 2025 · 6 MIN

Steering Treatments for Major Depressive Disorder

from MedEvidence Articles · host MedEvidence Articles

In this week's episode we review Major Depressive Disorder, a common mental disorder affecting millions of Americans. We explore who this disorder affects, what happens in the brain and body, and what treatments are available. We also get into the psychadellic substance psilocybin (psylocin) and how this breakthrough therapy may help those with Major Depressive Disorder.References:Substance Abuse and Mental Health Services Administration. (2019). Key substance use and mental health indicators in the United States: Results from the 2018 National Survey on Drug Use and Health. HHS Publication No. PEP19-5068, NSDUH Series H-54, 170, 51-58. https://www.samhsa.gov/data/sites/default/files/reports/rpt39443/2021NSDUHNNR122322/2021NSDUHNNR122322.htm#majorMarx, W., Penninx, B. W., Solmi, M., Furukawa, T. A., Firth, J., Carvalho, A. F., & Berk, M. (2023). Major depressive disorder. Nature Reviews Disease Primers, 9(1), 44. https://www.nature.com/articles/s41572-023-00454-1Daws, R. E., Timmermann, C., Giribaldi, B., Sexton, J. D., Wall, M. B., Erritzoe, D., ... & Carhart-Harris, R. (2022). Increased global integration in the brain after psilocybin therapy for depression. Nature medicine, 28(4), 844-851.https://www.nature.com/articles/s41591-022-01744-zLing, S., Ceban, F., Lui, L. M., Lee, Y., Teopiz, K. M., Rodrigues, N. B., ... & McIntyre, R. S. (2022). Molecular mechanisms of psilocybin and implications for the treatment of depression. CNS drugs, 36(1), 17-30. https://link.springer.com/article/10.1007/s40263-021-00877-yKuypers, K. P. (2020). The therapeutic potential of microdosing psychedelics in depression. Therapeutic advances in psychopharmacology, 10, 2045125320950567. https://journals.sagepub.com/doi/full/10.1177/2045125320950567Metaxa, A. M., & Clarke, M. (2024). Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis. BMJ, 385. https://www.bmj.com/content/385/bmj-2023-078084.abstractShare with a friend. Rate, Review, and Subscribe to MedEvidence! Articles to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramTwitterLinkedInTiktokYoutubeFor more great content, including discussions by physicians and clinical research experts, check out the MedEvidence! Podcast and MedEvidence.comThank you for listening!

Episode metadata supplied by the publisher feed · Published Jul 14, 2025

Embed this episode

In this week's episode we review Major Depressive Disorder, a common mental disorder affecting millions of Americans. We explore who this disorder affects, what happens in the brain and body, and what treatments are available. We also get into the psychadellic substance psilocybin (psylocin) and how this breakthrough therapy may help those with Major Depressive Disorder. References: Substance Abuse and Mental Health Services Administration. (2019). Key substance use and mental health indica...

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Steering Treatments for Major Depressive Disorder

0:00 6:20

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of MedEvidence Articles?

This episode is 6 minutes long.

When was this MedEvidence Articles episode published?

This episode was published on July 14, 2025.

Can I download this MedEvidence Articles episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!